Skip to main content
. 2020 Sep 21;162(11):2683–2693. doi: 10.1007/s00701-020-04579-0

Table 1.

Patient demographics and clinical characteristics with 15 different patients and 69 distinct bolus infusions of HTS

Characteristics N (%) or median (interquartile range)
n (patients) 15
Age 35 (23–54)
Sex (male) 11 (73.3%)
Best GCS 7 (6–8)
Best GCS-motor 5 (4–5)
Pupillary light reflex
Bilateral reactive 9 (60%)
Unilateral unreactive 4 (26.6%)
Bilateral unreactive 2 (13.3%)
Pre-hospital hypoxia 10 (66.6%)
Pre-hospital hypotension 2 (13.3%)
CT-epidural hematoma 2 (13.3%)
Mean ISS 25 (25–27)
AIS-head/brain 5 (4.5–5)
Marshall classification category of 1st head-CT
III 4 (26.6%)
IV 6 (40%)
V 5 (33.3%)
Median GOSE outcome 1 month 4 (1–5)

Treatment was a 140-ml 7.5% hypertonic saline solution

AIS, abbreviated injury scale; CT, computed tomography; HTS, hypertonic saline; ISS, injury severity score; GCS, Glasgow coma score; GOSE, Glasgow Outcome Scale-Extended